Quantcast

Latest Overactive bladder Stories

2014-07-10 08:27:22

MINNEAPOLIS, July 10, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the first quarter ended June 30, 2014 after the market close on Thursday, July 24, 2014. The Company will host a conference call and webcast to discuss these results on Thursday, July 24, 2014 at 4:30 p.m. Eastern Time (3:30 p.m. Central...

2014-06-30 08:29:46

MINNEAPOLIS, June 30, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, reported that in the recently updated Overactive Bladder (OAB) treatment guideline from the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), Percutaneous Tibial Nerve Stimulation (PTNS) is...

2014-06-16 08:27:52

MINNEAPOLIS, June 16, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that it will participate in the 9th Annual JMP Securities Healthcare Conference on Tuesday, June 24. Rob Kill, President and CEO, will present at 1:00pm ET and meet with investors one on one at the conference at The Westin New York Grand Central. Attendance...

2014-06-02 08:29:20

~Roche Brings Deep Healthcare Industry and Business Strategy Experience MINNEAPOLIS, June 2, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Kevin H. Roche has been appointed to the Company's Board of Directors effective May 29, 2014. Mr. Roche will chair the Nominating Committee and also serve as a member of Uroplasty's...

2014-05-20 16:26:15

National Consumer Contest Will Award One Woman $10,000 to Help Realize Her Dream of Reinvention WHITEHOUSE STATION, N.J., May 20, 2014 /PRNewswire/ -- Merck Consumer Care, the makers of OXYTROL FOR WOMEN - the first and only over-the-counter treatment for overactive bladder (OAB) - and MORE magazine announced today findings from a survey of 1,857 women 50 and over on MORE's reader panel revealing that in a perfect world 97% of them would choose a variety of ways to reinvent...

urine not sterile
2014-05-19 08:55:27

Brett Smith for redOrbit.com - Your Universe Online Although urine has long-been thought to be sterile, a new study has found that not only can bacteria survive in urine – they are relatively prolific in women with overactive bladder (OAB). "Doctors have been trained to believe that urine is germ-free," said Linda Brubaker, dean of Loyola University Chicago’s Stritch School of Medicine (SSOM) and an investigator in the new study, which was presented on Sunday as part of the 2014...

2014-05-17 12:20:20

Panel discusses management, safety and efficacy of botulinum toxin to treat overactive and neurogenic bladder ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- While Botulinum toxin A (BTX-A) has become a household name for addressing wrinkles, two studies presented at the 109(th) Annual Scientific Meeting of the American Urological Association (AUA) are proving BTX-A to be more than just a cosmetic solution. During a joint press conference at the Orlando County Convention Center in...

2014-05-08 20:24:35

Company launches video to help raise awareness of the brand's history and impact on patients IRVINE, Calif., May 8, 2014 /PRNewswire/ -- Allergan, Inc. (NYSE: AGN) today announced the launch of a video recognizing the physician pioneers and patient communities who contributed to the development of BOTOX(®) (onabotulinumtoxinA), one of the most recognized pharmaceutical brands in the United States. The video kicks off a year-long campaign to commemorate the 25(th) anniversary of the first...

2014-05-01 08:35:10

MINNEAPOLIS, May 1, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) announced today that it will release financial results for the fourth quarter and fiscal year 2014 ended March 31, 2014 at the market close on Thursday, May 15, 2014. The Company will host a conference call and webcast to discuss these results on Thursday, May 15, 2014 at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). Rob Kill, President and Chief Executive Officer, and Brett Reynolds, Chief Financial Officer,...

2014-04-17 08:27:52

MINNEAPOLIS, April 17, 2014 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced that Daniel P. Merz has joined the Company as Vice President of Healthcare Affairs. In this role, he will oversee Uroplasty's strategy to educate payors and providers of the efficiency, effectiveness and overall value of the Company's products. He joins...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related